| MR编号 | DE/H/3112/001 |
|---|
| 药品名称 | Temozolomid Fresenius Kabi 5 mg Hartkapseln |
|---|
| 活性成分 | |
|---|
| 剂型 | Capsule, hard |
|---|
| 上市许可持有人 | Fresenius Kabi Deutschland GmbH
Else-Kröner-Str. 1
D-61352 Bad Homburg v.d.H. |
|---|
| 参考成员国 - 产品名称 | Germany (DE) Temozolomid Fresenius Kabi 5 mg Hartkapseln |
|---|
| 互认成员国 - 产品名称 | - Austria (AT)
- Belgium (BE)
Temozolomide Fresenius Kabi 5 mg capsules, hard/gélules/Hartkapseln - Bulgaria (BG)
- Cyprus (CY)
TEMOZOLOMIDE FRESENIUS KABI 5mg HARD CAPS - Croatia (HR)
Temozolomid Fresenius Kabi 5 mg tvrde kapsule - Czechia (CZ)
Temozolomide Fresenius Kabi 5 mg - Denmark (DK)
- Estonia (EE)
- Greece (GR)
- Spain (ES)
- Finland (FI)
- France (FR)
- Hungary (HU)
TEMOZOLOMID Fresenius Kabi 5-20-100-140-180-250 mg kemény kapszula - Ireland (IE)
- Iceland (IS)
- Italy (IT)
- Lithuania (LT)
Temozolomid Fresenius Kabi 5 mg kietosios kapsulės - Latvia (LV)
- Malta (MT)
Temozolomide Fresenius Kabi Capsules Hard 5mg - Netherlands (NL)
- Norway (NO)
- Poland (PL)
- Portugal (PT)
- Romania (RO)
Temozolamida Fresenius Kabi 5 mg capsule - Sweden (SE)
- Slovenia (SI)
- Slovakia (SK)
- United Kingdom (GB)
|
|---|
| 许可日期 | 2014/08/06 |
|---|
| 最近更新日期 | 2016/02/24 |
|---|
| 药物ATC编码 | |
|---|
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|